This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Specific Treatment

PHILIP P. ELLIS, M.D.; LAWRENCE A. WINOGRAD, M.D.

Arch Ophthalmol. 1962;68(5):600-609.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Vaccinia-immune globulin (VIG) only recently has become available for the treatment of complications of smallpox vaccination. This paper will review the problem of ocular vaccinia and will present our results in the treatment of 6 cases with vacciniaimmune globulin.

Ocular vaccinia is most likely to occur in patients who have not had previous successful vaccinations and in those previously vaccinated who do not have adequate antibody levels against the viruses of vaccinia and variola. The disease can result from autoinoculation when the patient touches his own active vaccination "take" and then his own eye. This form of inoculation is common in infants and small children. Eye inoculation may also result when a nonimmune person touches someone with an active primary take and transmits the virus on his fingers to his eye. Similarly, the condition may occur in people working with the vaccine.

Vaccination usually produces a lasting but not necessarily . . . [Full Text PDF of this Article]

Author Affiliations
Denver

From the Division of Ophthalmology, Department of Surgery, University of Colorado Medical School.

Footnotes
Submitted for publication May 2, 1962.

Read before the Section on Ophthalmology, 111th Annual Meeting of the American Medical Association, Chicago, June 27, 1962.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?